Services
>
Pharma Clinical Trial CRO

Pharma Clinical Trial CRO

Mobius supports pharma sponsors with clinical trial strategy, feasibility, site activation, monitoring, data quality review, vendor coordination, CRO oversight, and rescue support across the United States, Australia, and New Zealand.

Talk to Mobius about a pharma study

Pharma studies need controlled delivery

A pharma clinical trial needs more than a protocol and a site list. Sponsors need realistic feasibility, trained sites, clear safety and escalation workflows, monitoring that finds meaningful risk, and data review that protects the evidence the study was designed to generate.

Plan
Pressure-test protocol feasibility, endpoint practicality, site fit, visit burden, and vendor responsibilities before study start.
Run
Coordinate site activation, monitoring, data quality review, action tracking, and sponsor oversight with clear escalation.
Recover
Review underperforming studies where enrollment, monitoring, data quality, or vendor visibility has drifted.

When pharma sponsors come to Mobius

Sponsors usually need practical clinical operations judgement when the study plan is complex, the internal team is lean, or the current CRO model is not giving enough visibility.
01
Protocol feasibility needs pressure-testing. Eligibility, endpoints, assessments, visit windows, safety workflows, and participant burden may look workable on paper but create delivery risk at site level.
02
Sites need to be selected and activated carefully. The right sites need access to the target population, realistic workload capacity, trained staff, and clear expectations around data entry, safety reporting, and escalation.
03
Monitoring and data quality need tighter control. Sponsors may need support when monitoring reports are late, action items remain open, queries increase, or endpoint and safety data require closer review.
04
The study needs rescue or stronger oversight. Mobius can help when enrollment is slow, vendors are not escalating clearly, or the sponsor cannot see what is actually blocking progress.

Feasibility before the protocol becomes expensive to change

Pharma feasibility should test more than site interest. Sponsors need to know whether the target population exists in reachable volume, whether the endpoint and assessment schedule are practical, whether inclusion and exclusion criteria are too restrictive, and whether site teams can run the protocol under real workload.

Mobius helps sponsors review clinical and operational assumptions early so avoidable rescue risk is identified before activation begins.

Explore clinical trial strategy

Clinical trial strategy ->

Execution support across sites, vendors, and sponsor oversight

A controlled pharma study depends on reliable handoffs between sponsor, CRO, sites, monitors, data vendors, safety teams, laboratories, imaging providers, and other specialist vendors.

Mobius can support site activation, monitoring strategy, action-item tracking, issue escalation, data quality review, meeting cadence, vendor coordination, and sponsor-side oversight so the operational picture stays visible.

Explore clinical trial execution

Clinical trial execution ->

Safety, data quality, and inspection readiness

Pharma studies can become fragile when safety workflows, protocol deviations, endpoint data, source documentation, monitoring findings, and TMF records are not reviewed with enough discipline.

Mobius helps sponsors identify operational gaps, prioritise remediation, and keep study decisions and evidence quality connected. We do not replace specialist regulatory, legal, medical, or pharmacovigilance advice.

Explore regulatory-aware evidence planning

Regulatory-aware planning ->

When a pharma trial needs rescue

A pharma study may need rescue support when enrollment is behind, site activation has stalled, monitoring is backlogged, action items are not closing, data queries are increasing, safety workflows are unclear, or the current CRO is reporting activity without enough operational judgement.

Mobius can help sponsors review the study state, identify recoverable issues, strengthen CRO oversight, or plan a structured handover where the current model is no longer working.

Explore clinical trial rescue CRO support

Study rescue support ->

Related Mobius experience

Mobius supports clinical research programs across medical device, IVD, digital health, biotech, pharma, and patient-centred evidence programs.

AI
AI-powered skin cancer detection
FIH
Mitral valve innovation from early feasibility to pivotal study
Pivotal
World-first aspiration thrombectomy trial
Patient
Non-invasive pain relief device for pregnancy
See case studies ->

Questions sponsors ask about pharma clinical trial CRO support

Short answers for pharma sponsors planning, running, overseeing, or rescuing clinical studies.

What does a pharma clinical trial CRO support?

A pharma clinical trial CRO can support study strategy, feasibility, site activation, monitoring, data quality review, vendor coordination, safety-process oversight, sponsor reporting, and rescue planning. The right scope depends on the protocol, phase, countries, sites, vendors, and sponsor team.

Can Mobius support pharma studies in the United States?

Yes. Mobius supports clinical trial planning, execution, oversight, and rescue work across the United States, Australia, and New Zealand, including US-only studies and multi-region clinical programs.

Can Mobius support Phase II or Phase III studies?

Mobius can support Phase II and Phase III clinical trial planning and execution activities where the sponsor needs practical CRO support, site feasibility, monitoring, data quality oversight, vendor coordination, or rescue planning.

Does Mobius replace regulatory or medical advice?

No. Mobius supports regulatory-aware clinical operations and works alongside sponsor medical, regulatory, safety, and legal advisers where needed. We help connect the operational plan to the evidence and oversight the sponsor needs.

Can Mobius help rescue a pharma trial that is already underway?

Yes. Mobius can help assess an underperforming pharma study, including recruitment, site activation, monitoring backlog, data quality, vendor roles, safety workflows, escalation, and sponsor oversight. The first step is a practical current-state review.

Talk to Mobius ->

Talk to Mobius about a pharma clinical trial

Tell us what phase or study model you are planning, where the trial may run, what vendors or sites are involved, and where operational risk needs clearer oversight.

Schedule A Call